CN Patent
CN111320619A — 一种类酰胺类衍生物的杂质及用途
Assigned to Nhwa Pharmaceutical Corp · Expires 2020-06-23 · 6y expired
What this patent protects
一种类酰胺类衍生物的杂质及用途。本发明属于医药化学领域,具体涉及杂质A、杂质B和杂质G,及其制备方法以及作为式Ⅵ所示化合物质量控制的参照标准品的应用,
USPTO Abstract
一种类酰胺类衍生物的杂质及用途。本发明属于医药化学领域,具体涉及杂质A、杂质B和杂质G,及其制备方法以及作为式Ⅵ所示化合物质量控制的参照标准品的应用,
Drugs covered by this patent
- Rexulti (BREXPIPRAZOLE) · Otsuka
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.